Ultimovacs ASA Stock Forecast - 20 Period Moving Average
| ULTI Stock | NOK 2.07 0.02 0.98% |
The 20 Period Moving Average forecasted value of Ultimovacs ASA on the next trading day is expected to be 1.92 with a mean absolute deviation of 0.13 and the sum of the absolute errors of 5.17. Ultimovacs Stock Forecast is based on your current time horizon.
Ultimovacs |
Ultimovacs ASA 20 Period Moving Average Price Forecast For the 28th of November
Given 90 days horizon, the 20 Period Moving Average forecasted value of Ultimovacs ASA on the next trading day is expected to be 1.92 with a mean absolute deviation of 0.13, mean absolute percentage error of 0.03, and the sum of the absolute errors of 5.17.Please note that although there have been many attempts to predict Ultimovacs Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ultimovacs ASA's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Ultimovacs ASA Stock Forecast Pattern
| Backtest Ultimovacs ASA | Ultimovacs ASA Price Prediction | Buy or Sell Advice |
Ultimovacs ASA Forecasted Value
In the context of forecasting Ultimovacs ASA's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ultimovacs ASA's downside and upside margins for the forecasting period are 0.02 and 8.58, respectively. We have considered Ultimovacs ASA's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Ultimovacs ASA stock data series using in forecasting. Note that when a statistical model is used to represent Ultimovacs ASA stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 77.9096 |
| Bias | Arithmetic mean of the errors | -0.0438 |
| MAD | Mean absolute deviation | 0.1262 |
| MAPE | Mean absolute percentage error | 0.0653 |
| SAE | Sum of the absolute errors | 5.1725 |
Predictive Modules for Ultimovacs ASA
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ultimovacs ASA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Ultimovacs ASA
For every potential investor in Ultimovacs, whether a beginner or expert, Ultimovacs ASA's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ultimovacs Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ultimovacs. Basic forecasting techniques help filter out the noise by identifying Ultimovacs ASA's price trends.Ultimovacs ASA Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ultimovacs ASA stock to make a market-neutral strategy. Peer analysis of Ultimovacs ASA could also be used in its relative valuation, which is a method of valuing Ultimovacs ASA by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Ultimovacs ASA Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ultimovacs ASA's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ultimovacs ASA's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Ultimovacs ASA Market Strength Events
Market strength indicators help investors to evaluate how Ultimovacs ASA stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ultimovacs ASA shares will generate the highest return on investment. By undertsting and applying Ultimovacs ASA stock market strength indicators, traders can identify Ultimovacs ASA entry and exit signals to maximize returns.
Ultimovacs ASA Risk Indicators
The analysis of Ultimovacs ASA's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ultimovacs ASA's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ultimovacs stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.68 | |||
| Standard Deviation | 6.62 | |||
| Variance | 43.88 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Ultimovacs Stock
Ultimovacs ASA financial ratios help investors to determine whether Ultimovacs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ultimovacs with respect to the benefits of owning Ultimovacs ASA security.